US 12285473
Cancer vaccines targeting MUC16 and uses thereof
granted A61KA61K2039/53A61K2039/54
Quick answer
US patent 12285473 (Cancer vaccines targeting MUC16 and uses thereof) held by Inovio Pharmaceuticals, Inc. expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/572, A61K39/00117